KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Senseonics Holdings (SENS) Long-Term Debt Repayments (2016 - 2025)

Senseonics Holdings (SENS) reported Long-Term Debt Repayments of $20.4 million for Q1 2025, up 148.77% on a QoQ basis from $8.2 million in Q4 2023.

Senseonics Holdings (SENS) has 7 years of Long-Term Debt Repayments data on file, last reported at $20.4 million in Q1 2025.

  • Quarterly Long-Term Debt Repayments changed N/A year-over-year to $20.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $20.4 million (changed N/A YoY) and the FY2025 annual result came in at $20.4 million, changed N/A from the prior year.
  • Long-Term Debt Repayments advanced to $20.4 million in Q1 2025 per SENS's latest filing, from $8.2 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $20.4 million in Q1 2025 and bottomed at -$8.2 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Senseonics Holdings 316.18 Mn 251.85 Mn 6.94 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 20.40 Mn
Mar 31, 2025 20.40 Mn
Dec 31, 2023 8.20 Mn
Dec 31, 2023 8.20 Mn
Sep 30, 2023 -8.20 Mn
Sep 30, 2023 -8.20 Mn
Mar 31, 2023 15.70 Mn
Mar 31, 2023 15.70 Mn
Sep 30, 2020 17.65 Mn
Sep 30, 2020 17.65 Mn
Jun 30, 2020 24.40 Mn
Jun 30, 2020 24.40 Mn
Mar 31, 2020 48.40 Mn
Mar 31, 2020 48.40 Mn
Dec 31, 2019 22.00 Mn
Dec 31, 2019 22.00 Mn
Sep 30, 2019 10.00 Mn
Sep 30, 2019 10.00 Mn
Jun 30, 2019 2.50 Mn
Jun 30, 2019 2.50 Mn
Mar 31, 2019 2.50 Mn
Mar 31, 2019 2.50 Mn
Dec 31, 2018 9.98 Mn
Dec 31, 2018 9.98 Mn
Jun 30, 2018 -2.48 Mn
Jun 30, 2018 -2.48 Mn
Mar 31, 2018 2.50 Mn
Mar 31, 2018 2.50 Mn
Dec 31, 2017 21,000.00
Dec 31, 2017 21,000.00
Sep 30, 2017 19,000.00
Sep 30, 2017 19,000.00
Sep 30, 2016 -784,000.00
Sep 30, 2016 -784,000.00
Jun 30, 2016 10.78 Mn
Jun 30, 2016 10.78 Mn
Mar 31, 2016 2.50 Mn
Mar 31, 2016 2.50 Mn